Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4

References

• Pandol S, Gukovskaya A, Edderkaoui M, Dawson D, Eibl G, Lugea A. Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J GastroenterolHepatol 2012; 27:Suppl 2 127 - 34; http://dx.doi.org/10.1111/j.1440-1746.2011.07013.x; PMID: 22320930
   PubMedGoogle Scholar
• Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011; 378:607 - 20; http://dx.doi.org/10.1016/S0140-6736(10)62307-0; PMID: 21620466
   PubMed Web of Science ®Google Scholar
• Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev ClinOncol 2010; 7:163 - 72; http://dx.doi.org/10.1038/nrclinonc.2009.236; PMID: 20101258
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Dasso M. Running on Ran: nuclear transport and the mitotic spindle. Cell 2001; 104:321 - 4; http://dx.doi.org/10.1016/S0092-8674(01)00218-5; PMID: 11239388
   PubMed Web of Science ®Google Scholar
• Güttler T, Görlich D. Ran-dependent nuclear export mediators: a structural perspective. EMBO J 2011; 30:3457 - 74; http://dx.doi.org/10.1038/emboj.2011.287; PMID: 21878989
   PubMed Web of Science ®Google Scholar
• Dasso M. The Ran GTPase: theme and variations. CurrBiol 2002; 12:R502 - 8; http://dx.doi.org/10.1016/S0960-9822(02)00970-3; PMID: 12176353
   PubMed Web of Science ®Google Scholar
• Sazer S, Dasso M. The ran decathlon: multiple roles of Ran. J Cell Sci 2000; 113:1111 - 8; PMID: 10704362
   PubMed Web of Science ®Google Scholar
• Deng L, Lu Y, Zhao X, Sun Y, Shi Y, Fan H, Liu C, Zhou J, Nie Y, Wu K, et al. Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins. BiochemBiophys Res Commun 2013; 440:322 - 9; http://dx.doi.org/10.1016/j.bbrc.2013.09.079; PMID: 24076388
   PubMed Web of Science ®Google Scholar
• Abe H, Kamai T, Shirataki H, Oyama T, Arai K, Yoshida K. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int J Cancer 2008; 122:2391 - 7; http://dx.doi.org/10.1002/ijc.23400; PMID: 18241036
   PubMed Web of Science ®Google Scholar
• Barrès V, Ouellet V, Lafontaine J, Tonin PN, Provencher DM, Mes-Masson AM. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol Cancer 2010; 9:272; http://dx.doi.org/10.1186/1476-4598-9-272; PMID: 20942967
   PubMed Web of Science ®Google Scholar
• Fan H, Lu Y, Qin H, Zhou Y, Gu Y, Zhou J, Wang X, Fan D. High Ran level is correlated with poor prognosis in patients with colorectal cancer. Int J ClinOncol 2013; 18:856 - 63; http://dx.doi.org/10.1007/s10147-012-0465-x; PMID: 22956174
   PubMed Web of Science ®Google Scholar
• Clarke PR, Zhang C. Spatial and temporal coordination of mitosis by Ran GTPase. Nat Rev Mol Cell Biol 2008; 9:464 - 77; http://dx.doi.org/10.1038/nrm2410; PMID: 18478030
   PubMed Web of Science ®Google Scholar
• Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 2004; 4:106 - 17; http://dx.doi.org/10.1038/nrc1274; PMID: 14732865
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhao X, Li K, Luo G, Nie Y, Shi Y, Zhou Y, Ren G, Feng B, Liu Z, et al. Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran. Antioxid Redox Signal 2013; 19:899 - 911; http://dx.doi.org/10.1089/ars.2012.4736; PMID: 23311631
   PubMed Web of Science ®Google Scholar
• Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS, El-Tanani MK. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 2008; 27:7139 - 49; http://dx.doi.org/10.1038/onc.2008.325; PMID: 18794800
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, et al, European Study Group for Pancreatic Cancer. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358:1576 - 85; http://dx.doi.org/10.1016/S0140-6736(01)06651-X; PMID: 11716884
   PubMed Web of Science ®Google Scholar
• Keleg S, Büchler P, Ludwig R, Büchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer 2003; 2:14; http://dx.doi.org/10.1186/1476-4598-2-14; PMID: 12605717
   PubMedGoogle Scholar
• Mellado B, Codony J, Ribal MJ, Visa L, Gascón P. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. ClinTranslOncol 2009; 11:5 - 10; http://dx.doi.org/10.1007/s12094-009-0304-3; PMID: 19155198
   PubMedGoogle Scholar
• Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. Androgen receptor and invasion in prostate cancer. Cancer Res 2008; 68:1128 - 35; http://dx.doi.org/10.1158/0008-5472.CAN-07-1929; PMID: 18281488
   PubMed Web of Science ®Google Scholar
• Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. EMBO Mol Med 2013; 5:1383 - 401; http://dx.doi.org/10.1002/emmm.201202367; PMID: 23982944
   PubMed Web of Science ®Google Scholar
• Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray RB, Chang C, Yokosuka O. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer 2010; 1:859 - 67; http://dx.doi.org/10.1177/1947601910383417; PMID: 21779469
   PubMedGoogle Scholar
• Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14:171 - 9; http://dx.doi.org/10.1016/j.semcancer.2003.10.003; PMID: 15246052
   PubMed Web of Science ®Google Scholar
• Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB. CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoS One 2014; 9:e90400; http://dx.doi.org/10.1371/journal.pone.0090400; PMID: 24594697
   PubMedGoogle Scholar
• Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, Bhat K, Wang F, Wu E, Wang Z. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett 2012; 322:169 - 76; http://dx.doi.org/10.1016/j.canlet.2012.02.035; PMID: 22450749
   PubMed Web of Science ®Google Scholar
• Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, Chen YH, Lai CH, Chen YF, Leung YM, Fu WM. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 2009; 613:146 - 54; http://dx.doi.org/10.1016/j.ejphar.2009.03.001; PMID: 19285061
   PubMed Web of Science ®Google Scholar
• Wong CH, Chan H, Ho CY, Lai SK, Chan KS, Koh CG, Li HY. Apoptotic histone modification inhibits nuclear transport by regulating RCC1. Nat Cell Biol 2009; 11:36 - 45; http://dx.doi.org/10.1038/ncb1810; PMID: 19060893
   PubMed Web of Science ®Google Scholar